Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Phio Pharmaceuticals
AddedFeb 19, 2024
UpdatedJun 18, 2026
Phio Pharmaceuticals

Phio Pharmaceuticals

Public

Phio Pharmaceuticals, a Massachusetts-based company, specializes in cancer immunotherapy and other medicines.

HQ
Marlborough, MA, US
Founded
2011
Overview
Compare
Fundraising
Employees
Website

Phio Pharmaceuticals, based in Marlborough, Massachusetts, is a clinical-stage biotech company co-founded by a Nobel Prize-winning scientist. The company's core mission is to advance cancer immunotherapy through innovative RNA interference (RNAi) technologies. Phio's proprietary INTASYL® platform enhances the effectiveness of immune cells in targeting and destroying tumor cells. Their market focus is primarily on developing treatments for various types of cancer, leveraging their cutting-edge RNAi solutions.

Notable affiliated individuals include the Nobel Prize-winning co-founder who discovered RNA interference. Phio Pharmaceuticals has attracted significant attention and investment due to its groundbreaking approach to cancer treatment. Key achievements include the development and clinical progression of their INTASYL® technology, which has shown promise in preclinical and early clinical trials. The overall impact of Phio Pharmaceuticals lies in its potential to revolutionize cancer immunotherapy, offering new hope for more effective and targeted cancer treatments.

Phio Pharmaceuticals - Similar Companies

Alnylam Pharmaceuticals aln logo

Alnylam Pharmaceuticals aln

alnylam.com

Ionis Pharmaceuticals logo

Ionis Pharmaceuticals

ionispharma.com

Photonpharma logo

Photonpharma

photonpharma.net

Quark Pharmaceuticals logo

Quark Pharmaceuticals

PIC Therapeutics logo

PIC Therapeutics

Phigenix logo

Phigenix

phigenix.com

PIN Pharma logo

PIN Pharma

pinpharma.com

Pheast Therapeutics logo

Pheast Therapeutics

pheast.com

Camino Pharma logo

Camino Pharma

caminopharma.com

Karyopharm Therapeutics logo

Karyopharm Therapeutics

karyopharm.com

Phoenix Biotechnology logo

Phoenix Biotechnology

Novita Pharmaceuticals logo

Novita Pharmaceuticals

novita-pharm.com

Phanes Therapeutics logo

Phanes Therapeutics

phanesthera.com

Kylin Therapeutics logo

Kylin Therapeutics

OncXerna Therapeutics logo

OncXerna Therapeutics

oncxerna.com

Phio Pharmaceuticals - Quick Facts

Who are Phio Pharmaceuticals' competitors?

Companies similar to Phio Pharmaceuticals include Alnylam Pharmaceuticals aln, Ionis Pharmaceuticals, Photonpharma and Quark Pharmaceuticals.

When was Phio Pharmaceuticals founded?

Phio Pharmaceuticals was founded in 2011.

Where is Phio Pharmaceuticals' headquarters located?

Phio Pharmaceuticals' headquarters is located in Marlborough, MA, US.

When was Phio Pharmaceuticals' last funding round?

Phio Pharmaceuticals' most recent funding round was for $2.8M (USD) in December 2023.

How much has Phio Pharmaceuticals raised to-date?

As of Dec 7, 2023, Phio Pharmaceuticals has raised a total of $112.2M (USD).

How many employees does Phio Pharmaceuticals have?

Phio Pharmaceuticals has 9 employees as of Feb 6, 2024.

Phio Pharmaceuticals - Classification

Ownership
  • Public
Technology
  • Biotech
  • RNAI
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Cancer Treatment
Unique IDs
  • ein: 453215903
  • secCik: 0001533040
  • ticker: PHIO
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research